Parasite Resistance in US Cattle Donald H. Bliss1, PhD; Robert D. Moore2, MS; William G. Kvasnicka3, DVM 1Veterinary Parasitologist, MidAmerica Ag Research, 3705 Sequoia Trail, Verona, WI 53593 2College of Agriculture, Biotechnology & Natural Resources, University of Nevada, Reno, NV 89557 37131 Meadow View, Shawnee, KS 66227 Abstract
s’ensuivre à l’insu des producteurs sauf si ces derni-ers ont un moyen simple de déterminer l’efficacité du
Parasite resistance to the macrocyclic lactones
produit. Le test de la réduction du nombre d’œufs fécaux
(ivermectin, doramectin, eprinomectin, and moxidec-
est un simple test recommandé par l’American Associa-
tin) is receiving considerable attention in the US cattle
tion of Veterinary Parasitologists (AAVP) qui permet aux
industry at a time when the economics of parasitism
praticiens d’aider les producteurs à déterminer le plus
constitute one of the most important factors involved
facilement si les vermicides qu’ils utilisent sont encore
in beef production. Knowing whether a dewormer is
effectifs. Ce test fécal implique une vérification fécale au
effective is extremely important to an operation. If para-
moment du traitement et ensuite 14 jours après traite-
sites become resistant to a particular product or product
ment. Entre l’automne 2007 et l’été 2008, l’accès gratuit
formulation, a serious problem can develop unknowingly
au laboratoire a été offert aux praticiens bovins à la
unless producers have an easy way to determine product
grandeur des États-Unis afin de leur permettre de faire
efficacy. The fecal egg count reduction test (FECRT) is a
le test fécal pour leurs clients. Un protocole standardisé
simple test recommended by the American Association
a été adopté impliquant un minimum de 20 échantil-
of Veterinary Parasitologists (AAVP) as the best way
lons par groupe de traitement aux deux moments
for the practitioner to help producers verify that the
d’échantillonnage. Les résultats sont consignés dans une
dewormer(s) they are using is effective. The FECRT in-
banque de données nationale sous la tutelle d’Intervet/
volves conducting a fecal check at the time of treatment
Schering-Plough Animal Health et de l’université de
and again 14 days following treatment. In the fall of 2007
Nevada-Reno. Plus de 58 cliniques vétérinaires dans 19
continuing through the summer of 2008, free lab support
états participent déjà au programme. Il y a plus de 119
was offered to bovine practitioners throughout the US
tests distincts impliquant 4765 échantillons avec une
to conduct FECRTs with their clients. This was done
panoplie de produits et de formulations. Ces données
according to a standard protocol involving a minimum
confirment que la résistance aux lactones macrocycliques
of 20 samples per treatment group at each collection
est étendue et il faut donc une vigilance soutenue de la
time. The results are being recorded in a national data
part du corps professionnel vétérinaire car le problème
base supported by Intervet/Schering-Plough Animal
semble maintenant au point critique et il y a des pertes
Health and the University of Nevada-Reno. Over 58
de millions de dollars de production en jeu.
veterinary clinics in 19 states have already participated in this program, with over 119 separate tests involving
Introduction
4,765 samples using a wide range of products and for-mulations. These data confirm that macrocyclic lactone
Deworming beef and dairy cattle in the US has
resistance is widespread and that continued vigilance is
evolved over the past 25 years to become a standard
required by the veterinary profession, since the problem
recommended practice on many progressive operations,
now appears to be at a critical stage with millions of
with emphasis on the economic benefits of deworming.
dollars in production losses at stake.
Each year, more producers are preventively deworm-ing their cattle at strategic times of the year to prevent
Résumé
economic losses caused by parasitism, rather than waiting to deworm cattle until after these animals are
La résistance des parasites aux lactones macro-
harboring heavy burdens and significant damage to the
cycliques (ivermectine, doramectine, éprinomectine et
animals has already occurred. Most producers are con-
moxidectine) attire beaucoup l’attention de l’industrie
cerned about deworming at the optimal time to achieve
du bétail aux États-Unis à un moment où les retom-
maximum benefit. These producers appreciate having
bées économiques des parasites constituent l’un des
highly efficacious formulations that are safe and easy
principaux facteurs touchant la production bovine. Il
to apply, and trust that the efficacy claim approved for
est extrêmement important qu’une opération connaisse
l’efficacité des vermicides. Si les parasites développent
The economic importance of parasitism is chang-
une résistance à un produit particulier ou à une formula-
ing as animal production becomes more efficient due to
tion particulière du produit, un sérieux problème peut
continued improvements in genetic, nutrition, implant
technologies, and disease control measures. A recent
ing programs practiced and the overall management
study from Iowa State University identified parasite
goals of the operation. The success or failure of these
control as the single most important economic factor in
strategically timed programs depend upon a number of
producing beef efficiently. This study identified parasites
factors, one of the most important being the ability of
as a major detriment to efficient production and that
the anthelmintic to stop parasite eggs being shed back
parasites are responsible for adding as much as $190 per
on the pastures, especially during the early part of the
animal to the cost of raising beef cattle.25 The economics
grazing season. If the anthelmintic fails to stop worm-
of parasitism calculated for this analysis came from the
egg shedding and cattle continue to shed worm eggs
effects of parasitism upon reproductive efficiency, rate
back on the pasture following treatment, the potential
of gain, feed efficiency, carcass quality, milk production
for pasture cleanup is greatly reduced or, in many cases,
and the immune system through reduced mortality and
The failure of the endectocide pour-ons to elimi-
It is apparent that as animals become more ef-
nate worm egg shedding was identified soon after the
ficient, it takes fewer parasites to cause economic loss
endectocide pour-ons were first introduced on the U.S.
than in less efficient animals. Studies at the University
market.8,16,23,34 This continual shedding predisposed the
of Wisconsin demonstrated that cows in early lactation
surviving parasites and their progeny to develop resis-
had greater production loss due to parasite exposure
tance to the macrocyclic lactone (ML) compounds used
than cows exposed to parasites later in lactation when
in the pour-on formulations. Since parasite survival
production stresses were much less.5 A second study at
and continual egg shedding is occurring while these
the University of Wisconsin showed that improvement
chemical compounds are still active in the animals and
in milk production due to deworming was greatest in the
their feces, both the worms themselves and the eggs
best managed herds.4 It takes fewer parasites, therefore,
being shed on the pasture are exposed to the chemical
to cause economic loss in a dairy cow milking 30,000
residue of the compounds in the feces. This reduced ef-
lb (13,636 kg) of milk per lactation than one milking
ficacy and continual product exposure by the parasites
15,000 lb (6,818 kg) per lactation or in a feedlot animal
over time creates the potential for parasite resistance
gaining 4.4 lb (2 kg) per day versus an animal gaining
to develop to these compounds.13,14,27 This problem is
2.2 lb (1 kg) per day. The more efficient an animal is, the
compounded by the “persistent efficacy” feature by these
greater impact parasites can have on maintaining this
pour-on products. Based on FDA approvals, these prod-
efficiency. When parasites are missed by an inefficient
ucts exhibit persistent residues in the animals ranging
dewormer or because of anthelmintic resistance, unless
from 14 to 42 days following treatment depending upon
detected quickly, these parasites can be very damaging
the product involved. The persistent residues indicate
to an operation not only through production losses, but
prolonged exposure of the surviving parasites in the
also by the continued contamination of the animal’s
gastrointestinal tract and parasite offspring (larvae)
environment ensuring future infections.
surviving in the manure to the ML compounds, thereby
Based on research conducted on the benefits of
greatly increasing the chance for development of para-
strategically timed deworming, considerable efforts
site resistance to these compounds.2 Recent data, in fact,
have been made to teach veterinarians, nutritionists,
indicate that parasite resistance is now a real threat
pharmaceutical representatives, feed company repre-
in operations where ML pour-ons have been used for
sentatives and producers about these benefits.6,8,11,22,31,32,33
A number of companies have created FDA approved
The reason for the reduced efficacy with ML pour-
formulations that facilitate the ease of deworming for
ons has been identified as the lack of consistent and
the producer. These formulations include many non-
adequate level of absorption by the endectocide pour-
handling forms such as medicated blocks, medicated
ons into the bloodstream, when compared to injectable
free-choice minerals, medicated range cube or cake
formulations of the same products.15 Blood level de-
supplements, medicated complete feeds and top-dressed
terminations following treatment with doramectin in
feed formulations, liquid supplements as well as topi-
an injectable formulation demonstrated 90% absorbed
while the pour-on formulation was only 15% absorbed.
The goal of strategically timed anthelmintic appli-
Absorption data is given as follows: 200 mg/kg inject-
cation is to prevent economic loss and reduce environ-
able ML will deliver a maximum plasma concentration
mental parasite contamination by eliminating worm-egg
with a mean of 32ng/ml, while a 500 mg/kg pour-on ML
shedding for a period of time at least equal to the life
will deliver a maximum plasma concentration with a
cycle of the parasites removed.1,6,20 This strategy entails
mean of 12ng/ml. This reduced blood level (12ng/ml
more than simply applying a dewormer. The timing
versus 32ng/ml) indicates that many animals may not
of the deworming is very important, and things to be
be receiving a therapeutic dose following treatment
considered include the season of the year, type of graz-
with the ML pour-on formulations and the parasites
and their offspring are predisposed to possible parasite
efficacy value of 74.7% was achieved for moxidectin in
resistance. Also, the adult parasites and newly develop-
Phase 1 of the second trial and an efficacy value of 0%
ing adults that survive pour-on treatment continue to
in the second phase of the second trial. Fenbendazole
produce eggs that are shed back into the environment
maintained an efficacy value of greater than 95% in both
of the animals, making these ML pour-ons unsuitable
trials. The fecal worm-egg count results from this study
for use in a strategic deworming program.
revealed that the parasites which survived the first ML
The history of the detection of anthelmintic resis-
treatment were refractory to a second ML treatment,
tance in cattle began as early as 1997 when a FECRT
indicating that the ML pour-ons selected for resistant
conducted in New Zealand showed that the ML pour-ons
parasites during the first exposure were then resistant
(moxidectin and ivermectin) failed to control parasites
to further treatment by any ML compound.
as well as an ML injectable formulation (doramectin).17 Then in 1999, a FECRT conducted in Louisiana showed
Materials and Methods
weekly samples taken for eight weeks following treat-ment with ivermectin pour-on and doramectin pour-on
The fecal worm egg reduction test (FECRT) is
ranged from 50 to 79% efficacy for doramectin and 43%
now recommended as a field test to determine whether
to 85% for ivermectin.37 This study demonstrated that
treatment is successful and that a FECRT with efficacy
parasite resistance was already present in Louisiana.
less than 90% indicates that anthelmintic resistance is
The first field study where parasite resistance was con-
present.13,35,37 In the fall of 2007 and continuing through
firmed with worm counts at necropsy in a critical efficacy
the end of the summer of 2008, a nationwide survey was
study was conducted in Wisconsin.16,32 In this study, the
set-up to determine the scope and scale of ML resistance.
efficacy of doramectin, moxidectin, eprinomectin and
FECRTs were offered free to veterinary clinics all across
Ivomec® Plus (Merial) was tested. Comparing worm
the US by Intervet/Schering-Plough Animal Health as
counts to non-medicated control cattle, the efficacy of
a valuable tool for practitioners to test whether a par-
moxidectin was 88.0%, doramectin was 64.1%, eprino-
ticular product of choice was working for their clients.
mectin was 73.1% and Ivomec® Plus was 0%. All four
A standard protocol was provided for each participating
compounds were identified as resistant, with efficacies
far below the desired efficacy of 90% or greater.32
Each participating clinic would identify a cooperat-
Eprinomectin and moxidectin were further inves-
ing producer with a minimum of 20 parasitized animals
tigated using the FECRT protocol in two separate com-
between six months and two year olds to conduct each
mercial beef herds owned by the University of Illinois
test. All sampling was done under the supervision of the
at the Dixon Spring Agricultural Station in Simpson,
participating clinic. Each participating veterinary clinic
Illinois to investigate whether the repeated use of eprino-
was offered two trials per clinic conducted free, plus each
mectin or moxidectin would lead to parasite resistance.16
clinic received additional compensation for their time
In the first phase of the first trial, 30 animals in each
involved in setting up and conducting the tests. Samples
herd received eprinomectin pour-on according to label
were collected at the time of treatment and again 14-
directions (0.5mg/kg BW). In the second phase, treated
days later. These samples were kept cool and sent with
animals from the first trials were ranked based on post-
ice packs to one of three separate parasitology labs for
treatment worm egg counts, blocked and randomly as-
analysis using the Modified Wisconsin Sugar Flotation
signed to one to two treatment groups. Fifteen animals
Method.11 All samples were blinded to treatment, and
from each herd received eprinomectin pour-on (0.5mg/kg
pre-treatment and post-treatment samples from the
BW), while the remaining 15 animals from each herd
same location were sent to the same lab.
received fenbendazole oral paste (5mg/kg BW). In the first phase of the second trial, 30 animals in each herd
received moxidectin pour-on according to label directions (0.5mg/kg BW). In the second phase, treated animals
Fifty-eight veterinary clinics located in 19 states
from the first trials were ranked based on post-treat-
have participated in the survey on parasite resistance,
ment worm-egg counts, blocked and randomly assigned
conducting 119 FECRTs involving 4,765 samples. The ef-
to one to two treatment groups. Fifteen animals from
ficacy of the injectable ML formulations was tested in 26
each herd received moxidectin pour-on (0.5mg/kg BW),
tests showing the efficacy of Ivomec® (Merial) at 76.2%,
while the remaining 15 animals from each herd received
Ivomec® Plus (Merial) at 42.6%, Dectomax® (Pfizer,
Inc.) at 89.9%, Cydectin® (Ft Dodge Animal Health) at
Results demonstrated that an efficacy value of
98.1% and ivermectin (generic) at 50.0%. The overall
84.8% was achieved for eprinomectin in Phase 1 of the
efficacy of the ML injectable formulations was 72.5%
first trial and an efficacy value of 5.5% in the second
(Table 1). The efficacy of the ML pour-on formulations
phase of the first trial. Results demonstrated that an
was tested in 60 tests showing the efficacy of Ivomec®
Table 1. Efficacy of macrocyclic lactone injectable formulations from FECRTs* conducted by veterinary practitioners
and submitted to Intervet’s national database. Injections: ** All samples taken at treatment and again two weeks post-treatment. Table 2. Efficacy of macrocyclic lactone pour-ons from FECRTs* conducted by veterinary practitioners and submit-
ted to Intervet’s national database. Pour-ons:
* Fecal egg count reduction tests. **All samples taken at treatment and again two weeks post-treatment.
at 72.3%, ivermectin (generic) at 59.7%, Dectomax®
mintic resistance to any product as efficacy values of
at 78.9% and Cydectin® at 67.2%. The overall efficacy
below 90%.15,38 Positive worm-egg counts two weeks fol-
of the ML pour-ons was 66.1% (Table 2). The efficacy
lowing treatment indicate incomplete kill, however, egg
of Safe-Guard®/Panacur® was tested in 24 tests with
counts don’t identify the size of the residue population
1,016 samples with a mean pre-treatment egg count
of parasites which remain in an animal after treatment.
of 67eggs/3gm and a mean post-treatment egg count
An extensive feedlot production study involving over
of 0.4 egg/3gm for an overall efficacy of 99.4% (Table
700 yearling cattle showed that a mean fecal worm-egg
3). In nine trials, a combination treatment was given,
count of 9.0 epg decreased gain by 4.2%, while a high
with either Safe-Guard® or Panacur® given at the same
worm burden with a mean fecal worm egg count of 47.0
time as a ML injectable or ML pour-on formulation with
epg decreased gain by 13.3%.33 The overall summary
either Ivomec®, Dectomax®, or Cydectin®. These tests
of all ML injectable formulations in 26 tests involving
involved 261 samples, with a mean pre-treatment count
884 cattle was a mean egg count of 21.8 eggs/3gm and
of 152.1 eggs/3gm and a mean post-treatment count
19.0 eggs/3gm for the ML pour-ons in 60 tests conducted
of 0.1 egg/3gm for an overall efficacy of 99.9% mean
with 2,486 cattle. Since these tests were conducted
across 19 states, it is evident that ML resistance is now
widespread and the cost of ML resistance to US cattle
Discussion
producers may be in the millions of dollars.
The dilemma which occurs for the US cattle pro-
The World Association for the Advancement of
ducer is that for many, ML formulations are an impor-
Veterinary Parasitology (WAAVP) has defined anthel-
tant part of their arsenal of products used to control
Table 3. Efficacy of various Safe-Guard®/Panacur® formulations from FECRTs* conducted by veterinary practi-
tioners and submitted to Intervet’s national database.
Safe-Guard®/Panacur® Overall summary**
* Fecal egg count reduction tests. **All samples taken at treatment and again two weeks post-treatment.
Table 4. Efficacy of Safe-Guard®/Panacur® in combination with various macrocyclic lactone formulations from
FECRTs* conducted by veterinary practitioners and submitted to Intervet’s national database.
Safe-Guard/Panacur Drench plus:Ivomec® Inj.
* Fecal egg count reduction tests. **All samples taken at time of treatment and again two weeks post-treatment.
external parasite (lice, mites, grubs and flies). In nine
3. Bisset SA: Efficacy of a topical formulation of ivermectin against
tests in 261 cattle, where fenbendazole was given at the
naturally acquired gastro-intestinal nematodes in weaner cattle. New
same time as a ML injectable or ML pour-on formulation,
4. Blackburn BL, Hanrahan LA, Hendrix CM, Lindsay DS: Evaluation
the FECRT indicated a mean efficacy of 99.9% across all
of three formulations of fenbendazole (10% suspension, 0.5% pellets
nine tests (Table 4). From these tests, it appears that
and 20% premix) against nematode infections in cattle. Am J Vet Res
whenever a ML formulation is used for external parasite
control, it should be used simultaneously with a non-ML
5. Bliss DH, Todd AC: Milk production by Wisconsin dairy cattle after deworming with Baymix®. Veterinary Medicine/Small Animal Clini-
internal parasiticide to prevent losses due to internal
cian (September) 1034-1038, 1973.
parasitisms and to prevent the further transfer of ML
6. Bliss DH, Todd AC: Milk losses in dairy cows after exposure to
infective trichostrongylid larvae: Veterinary Medicine/ Small Animal Clinician, 1612-1617 (October) 1977.
7. Bliss DH: The Cattle Producer’s Handbook for Strategic Parasite References Control. Somerville, NJ, Hoechst-Roussel Agri-Vet Company, 1988.
8. Bliss DH, Newby TJ: Efficacy of the morantel sustained-release
1. Armour J, Bairden K, Duncan JL, Jones RM., Bliss DH: Studies on
bolus in grazing cattle in North America. J Am Vet Med Assn 192:177-
the control of bovine ostertagiasis using a morantel sustained release
bolus. Vet Rec 108(25):532-535, 1981.
9. Bliss DH, Campbell J, Corwin RM, Kvasnicka W, Laurence L,
2. Barnes EH, Dobson RJ, Stein PA, LeJambre LF, Lenane LJ: Selec-
Strickland J, Whittier D: Strategic Deworming of Cattle (Parts 1-3),
tion of different genotype larvae and adult worms for anthelmintic
Roundtable Discussion. Agri-Pract 14(5):34-41, (6):32-37, (7):18-27,
resistance by persistent and short-acting avermectin- and moxidectin-
selected strains. Int J Parasitol 31:720-727, 2001.
10. Bliss DH: The worm egg shedding profile of ivermectin pour-on. Technical Bulletin, Hoechst Roussel Agri-Vet Co, Somerville, NJ, 1993.
11. Bliss DH, KvasnickaWG: The fecal exam: a missing link in food
27. Lawrence JD, Ibarburu MA: Economic Analysis of Pharmaceutical
animal practice. Compend Cont Ed Pract Vet April; 104-109, 1997.
Technologies in Modern Beef Production. Ames, Iowa State University,
12. Bliss DH, KvasnickaWG: Failure of avermectins to control an
outbreak of parasitic gastro-enteritis in a cow/calf herd. In: Proc 49th
28. Majia MF, Fernandez Igartua BM, Schmidt EE, Cabaret J: Mul-
Am Assoc Vet Parasitol. Philadelphia, PA, July 24-28 (Abstract 42),
tispecies and multiple anthelmintic resistance on cattle nematodes
in a farm in Argentina: the beginning of high resistance? Vet Res
13. Bumgarner SC, Brauer MA, Corwin RM, Thomas EA, Myers GH,
Strategic deworming for spring-calving beef cow/calf herds. Am J Vet
29. Prichard RK, Hall CA, Kelly JD, Martin ICA, Donald AD: The
problem of anthelmintic resistance in nematodes. Aus Vet J 56:239-
14. Campbell WC, Benz GW: Ivermectin: a review of efficacy and safety.
J Vet PharmacolTherap 7:1-16, 1984.
30. Prosl H, Superer R, Jones RM, Lockwood PW, Bliss DH: Morantel
15. Coles GC, Jackson F, Pomroy WE, Prichard RK, Samson-Himmel-
sustained release bolus: a new approach for the control of trichostron-
stjerma G von, Slivestre A, Taylor MA, Vercruysse J: The detection of
gylosis in Austrian Cattle. Vet Parasit 12:239-250, 1983.
anthelmintic resistance in nematodes of veterinary importance. Vet
31. Raynaud JB, Jones R M, Bliss DH, LeStang LP, Kerboeuf D: The
control of parasitic gastroenteritis of grazing cattle in Normandy,
16. Gasbarre LC, Smith LL, Lichtenfels JR, Pilitt PA: The identifi-
France, using the morantel sustained release bolus. Vet Parasitol
cation of cattle nematode parasites resistant to multiple classes of
anthelmintics in a commercial cattle population in the US. In: Proc
32. Smith LL, Gasbarre LC: The development of cattle nematode
49th American Assoc Vet Parasitol. Phildelphia, PA, July 24-28 (Ab-
parasites resistant to multiple classes of anthelmintic in a commer-
cial cattle population in the US. In: Proc 49th Am Assoc Vet Parasitol.
17. Gaynard V, Valvinerie M, Toutain PL: Comparison of persistent
Phildelphia, PA, July 24-28 (Abstract 43), 2004.
anthelmintic efficacy of doramectin and ivermectin pour-on formula-
33. Smith RA, Rogers KC, Husae S, Wray MI, Brandt RT, Hutcheson
tion in cattle. Vet Parasitol 81:47-55, 1999.
JP, Nichols WT, Taylor FT, Raines JR, McCauley CT, Pasture deworm-
18. Hart K, Bliss DH: Efficacy of macrocyclic lactone pour-on under
ing and (or) subsequent feedlot performance with fenbendazole. I. Ef-
field conditions. In Proceedings of: Proc 51st Am Assoc Vet Parasitol.
fects on grazing performance, feedlot performance and carcass traits
Honolulu, HI, July 15-18 (Abstract 60), 2006.
in yearling steers. Bov Pract 34:104-114, 2000.
19. Hooke FC, Clement D, Dell’Osa, Porter RM, MacColl D, Rew RS:
34. Stromberg BE, Vatthauer RJ, Schlotthauer JC, Myers GH, Hag-
Therapeutic and protective efficacy of doramectin injectable against
gard DL, King VL, Hanke H: Production responses following strategic
gastrointestinal nematodes in cattle in New Zealand: A comparison
parasite control in a beef cow/calf herd. Vet Parasitol 68:315-322,
with moxidectin and ivermectin pour-on formulations. VetParasitol
35. Stromberg B, Newcomb H, Bliss D, Hart K, Miller J, Gasbarre L,
20. Hoover RC, Lincoln SD, Newby TJ, Bliss DH: Controlling para-
Craig T, Laurence L: Proposed standardized testing for anthelmintic
sitic gastro-enteritis in pastured cattle. Vet Med, August: 1082-1086,
resistance determination. In: Proc 52nd Am Assoc Vet Parasitol.
21. Jacobs DE, Fox MT, Walker MJ, Jones RM, Bliss DH: Field evalu-
36. Williams JC, Loyacano AF, Broussard SD, Coombs DF, DeRosa
ation of a new method for the prophylaxis of parasitic gastroenteritis
A, Bliss DH: Efficacy of a spring strategic fenbendazole treatment
in calves. Vet Rec 108:274-251, 1981.
program to reduce numbers of Ostertagia ostertagi inhibited larvae
22. Jones RM: A field study of the morantel sustained release bolus
in beef stocker cattle. Vet Parasitol 59:127-137, 1995.
in the seasonal control of parasitic gastroenteritis in grazing calves.
37. Williams JC, Loyacano AF, DeRosa A, Gurie J, Clymer BC, Guerino
Vet Parasitol 8:237-245, 1981.
F: Comparison of persistent anthelmintic efficacy of topical formula-
23. Keith E A: Utilizing feed-grade formulations of fenbendazole for
tions of doramectin, ivermectin, eprinomectin and moxidectin against
cattle. Agri-Pract – Parasitology 13 (Jan), 1992.
naturally acquired nematode infection of beef calves. Vet Parasitol
24. Kvasnicka WG, Krysl LJ, Torell RC, Bliss DH: Cow/calf herd
investigation: fenbendazole in a strategic deworming program. The
38. Woods IB, Amaral NK, Bairden K, Duncan JK, Kassai T, Malone
Compendium, Food Animal Parasitology, April, 18:113-177, 1996.
JB, Pankavich JA, Reinecke RK, Slocombe O, Taylor SM, Vercruysse
25. Kvasnicka WG, Bliss DH, Torrel RC: Evaluation of anthelmintic
J: World Association for the Advancement of Veterinary Parasitology
treatments in cattle grazing Great Basin rangeland in Nevada and
(W.A.A.V.P.) second edition of guidelines for evaluation the efficacy of
California. In: Proc 42nd Am Assoc Vet Parasitol. Reno, NV, July 12-22
anthelmintics in ruminants (bovine, ovine, caprine). VetParasistol
26. Kvasnicka WG, Bliss DH: Field efficacy of endectocide pour-on
formulations against gastrointestinal nematodes. In: Proceedings of the 47th Am Assoc Vet Parasitol. Nashville, TN, July 13-16, 2002.
Paxil Litigation Going Strong on Multiple Fronts By C. Richard Newsome, Esq. and Jerri H. Coletti, Esq. Litigation surrounding the antidepressant drug Paxil continues to develop and evolve around the country. During the past year, Plaintiffs won a key victory in the first case to go to trial alleging birth defects caused by Paxil. The second birth defects case ended in dismissal. A large nu
STEVEN V. GRABIEC, MD EDUCATION College Degree A. B. pre-professional Medicine-University of Notre Dame honor graduate Medical Degree-State University of New York School of Medicine, Buffalo, NY Internship-Buffalo Children’s Hospital-Allergy and Immunology Residencies at buffalo Children’s Hospital-Allergy and Immunology Ireland Army Hospital Fort Knox, KY- Attendi